QIAGEN OmicSoft and Biomedical Knowledge Base
Checkpoint inhibitors investigation in context of biomarkers, drug targets and pathways using Omicsoft and Ingenuity Pathway Analysis
175 views
This training will focus on how QIAGEN Omicsoft Studio and IPA can be used to discover new biomarkers, validate (or study) drug targets and identify novel mechanisms of action with user and/or public checkpoint inhibitor datasets from resources like GEO, SRA, TCGA and more.
In this training, you will learn how to:
· Investigate the expression of a gene/biomarker/drug target across different treatments and diseases
· Derive a biomarker/gene signature from a specific condition (for example, non-responders of a drug, a specific disease/disease subtype and more)
· Correlate expression of multiple genes and biomarkers
· Compare different experimental groups (user and/or public data) at both gene expression and pathways/regulatory networks activity levels
Related videos
QIAGEN OmicSoft and Biomedical Knowledge Base
Exploring drug response in low-grade glioma
See how Dr, Nilson from QIAGEN Digital Insights navigates an interesting...
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug treatment data investigation using Omicsoft and Ingenuity Pathway Analysis
In this training, the trainer will go over how to utilize public drug...
QIAGEN OmicSoft and Biomedical Knowledge Base
Discoveries from public immuno-oncology studies using Omicsoft and Ingenuity Pathway Analysis
This training will focus on how QIAGEN Omicsoft Studio and Ingenuity Pathway...
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft
In this 90-minute training, you’ll learn how to do drug treatment, toxicology...